Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Invested Capital: 2021-2025

Historic Return on Invested Capital for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 0.63%.

  • Oncology Institute's Return on Invested Capital changed N/A to 0.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63%, marking a year-over-year change of. This contributed to the annual value of 0.44% for FY2023, which is 13300.0% down from last year.
  • Latest data reveals that Oncology Institute reported Return on Invested Capital of 0.63% as of Q3 2025.
  • Oncology Institute's 5-year Return on Invested Capital high stood at 1.56% for Q4 2022, and its period low was 0.65% during Q2 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.51% (2023), whereas its average is 0.27%.
  • In the last 5 years, Oncology Institute's Return on Invested Capital skyrocketed by 21600bps in 2022 and then plummeted by -20700bps in 2023.
  • Over the past 5 years, Oncology Institute's Return on Invested Capital (Quarter) stood at 0.6% in 2021, then soared by 360bps to 1.56% in 2022, then plummeted by -133bps to 0.51% in 2023, then rose by 1bps to 0.51% in 2024, then decreased by -24bps to 0.63% in 2025.
  • Its last three reported values are 0.63% in Q3 2025, 0.65% for Q2 2025, and 0.51% during Q2 2024.